Oligonucleotide Synthesis Market size to grow by USD 2,870.69 million from 2022 to 2027|Increasing research activities in the pharmaceutical and biotechnology sectors drive the market

/PRNewswire/ -- The oligonucleotide synthesis market size is estimated to increase by USD 2,870.69 million from 2022 to 2027. The market's growth momentum will...

Related Keywords

Canada ,Russia ,United States ,United Kingdom ,Japan ,China ,Ukraine ,Germany ,America ,Jesse Maida ,Agilent Technologies Inc ,Merck Kgaa ,Alnylam Pharmaceuticals Inc ,Kaneka Corp ,Biocon Ltd ,Ajinomoto Co ,Biogen Inc ,Sarepta Therapeutics Inc ,Danaher Corp ,Science Group Holdings Ltd ,Ionis Pharmaceuticals Inc ,Bio Synthesis Inc ,Merck Kga ,Data Table On Research ,Product Service ,Technavio Research ,Maravai Lifesciences Holdings Inc ,Thermo Fisher Scientific Inc ,Mettler Toledo International Inc ,Eurofins Scientific ,Group Holdings Ltd ,Synbio Technologies ,Technologies Inc ,Synthesis Market ,North America ,Oligonucleotide Synthesis Market ,Global Active Pharmaceutical Ingredients ,Market Positioning ,Competitive Strategies ,Executive Summary ,Data Table ,Global Market ,Market Segmentation ,Vendor Market ,Historic Market Size ,Segment Analysis ,Applications Segment ,End User Segment ,Geography Segment ,Country Segment ,Data Tables ,Agilent Technologies ,Alnylam Pharmaceuticals ,Ionis Pharmaceuticals ,Group Holdings ,Lifesciences Holdings ,Maravai Lifesciences Holdings ,Toledo International ,Mettler Toledo International ,Therapeutics Inc ,Fisher Scientific ,Thermo Fisher Scientific ,Technavio ,